MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

Model Number 0500316E

Device Problem Fluid/Blood Leak (1250)

Patient Problem No Clinical Signs, Symptoms or Conditions (4582)

Event Date 11/24/2021

Event Type  malfunction  

Manufacturer Narrative

The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.

Event Description

A materials manager reported that a dialyzer blood leak occurred during a hemodialysis (hd) treatment.In a follow up with the clinic manager, registered nurse (rn), it was clarified that the blood leak occurred almost immediately after the hd treatment began.The blood leak was noted as being an internal blood leak.The leak was visually observed.The machine, a fresenius 2008k machine, alarmed appropriately with a blood leak alarm.Blood leak test strips were not used.There was no damage noted on the dialyzer.The patient¿s estimated blood loss (ebl) was 75 ml.There was no patient injury, adverse events, or medical intervention required as a result of this event.The treatment was completed with the same machine and new supplies.The complaint device was reported to be available to be returned to the manufacturer for evaluation.

Manufacturer Narrative

Additional information: d.9., h.3.The customer returned a dialyzer from the reported lot for evaluation.During the visual examination of the sample, a delamination was observed on the cavity id end of the dialyzer extending from approximately 280° to 45°, with the dialysate ports situated at 0°.No other damage or irregularities were noted on the returned sample.A review of the production record was performed.The production record review showed there was one approved temporary deviation notice in the production of this lot.They are unrelated to the reported complaint event.There was no indication of product non-acceptance or deviation in the manufacturing process related to the complaint event.This includes non-conformances, rework, labeling, process controls, and any other occurrence in production that was potentially related to the complaint.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.There is no recall associated with this complaint.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program in order to assess and improve our products and processes.Capas for vision systems and blood leak reduction are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.

Event Description

A materials manager reported that a dialyzer blood leak occurred during a hemodialysis (hd) treatment.In a follow up with the clinic manager, registered nurse (rn), it was clarified that the blood leak occurred almost immediately after the hd treatment began.The blood leak was noted as being an internal blood leak.The leak was visually observed.The machine, a fresenius 2008k machine, alarmed appropriately with a blood leak alarm.Blood leak test strips were not used.There was no damage noted on the dialyzer.The patient¿s estimated blood loss (ebl) was 75 ml.There was no patient injury, adverse events, or medical intervention required as a result of this event.The treatment was completed with the same machine and new supplies.The complaint device was reported to be available to be returned to the manufacturer for evaluation.

• Brand Name: OPTIFLUX 160NRE DIALYZER FINISHED ASSY.
• Type of Device: DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
• Manufacturer (Section D): OGDEN MANUFACTURING PLANT; director, site quality; 475 west 13th street; ogden UT 84404
• Manufacturer (Section G): OGDEN MANUFACTURING PLANT; director, site quality; 475 west 13th street; ogden UT 84404
• Manufacturer Contact: jason busch ; 920 winter st; waltham, MA 02451 ; 9043166958
• MDR Report Key: 12894235
• MDR Text Key: 285172662
• Report Number: 1713747-2021-00440
• Device Sequence Number: 1
• Product Code: KDI
• UDI-Device Identifier: 00840861100149
• UDI-Public: 00840861100149
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: K002761
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Health Professional,User Facility
• Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup
• Report Date: 01/18/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 11/30/2021
• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Model Number: 0500316E
• Device Catalogue Number: 0500316E
• Device Lot Number: 21KU01018
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Date Returned to Manufacturer: 12/15/2021
• Device Age: MO
• Date Manufacturer Received: 01/12/2022
• Was Device Evaluated by Manufacturer?: Yes
• Date Device Manufactured: 08/30/2021
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Treatment: FRESENIUS 2008K MACHINE; FRESENIUS 2008K MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
• Patient Age: 49 YR
• Patient Sex: Male
• Patient Weight: 87 KG